Freenome, Inc. (NasdaqCM: FRNM)
Health Care · Biotechnology · US
$11.56
+3.68% today · +9.4% 1Y
Freenome, Inc. (NasdaqCM: FRNM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.30B and employs 363 people.
Over the last twelve months the share price has gained 9.4%, trading between 9.95 and 14.47.
Tweenvest scores Freenome, Inc. across four factors: quality 13/100, value 76/100. Its strongest factor is value.
FRNM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.30B
- Revenue (TTM)
- $34.24M
- P/E
- —
- EPS
- -8.47
- Dividend yield
- —
- Beta (5Y)
- 0.35
- 52-week high
- $14.47
- 52-week low
- $9.95
- Avg volume (3M)
- —
- Shares outstanding
- 112.86M
- Employees
- 363
- Next earnings
- —
About Freenome, Inc.
Perceptive Capital Solutions Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Eric Edelman, Adam Leo Stone, and Michael R. Altman on March 22, 2024 and is headquartered in New York, NY.
- ISIN
- US35661P1003
- Founded
- 2014
- Listed since
- Jul 21, 2026
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.43 | +0.18% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.98 | +0.38% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.44 | +0.22% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.78 | +0.13% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $825.89 | -0.98% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $139.44 | -3.88% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.